A nurse is caring for a patient receiving warfarin therapy. Which laboratory value requires the most immediate nursing intervention?

Warfarin therapy requires meticulous monitoring because of its narrow therapeutic index, a concept highlighted in the provided literature as a primary challenge in management ^[1]. The drug’s effectiveness and safety are quantified using the Prothrombin Time (PT) and its standardized derivative, the International Normalized Ratio (INR). For most indications, including atrial fibrillation and mechanical heart valves, the target therapeutic INR range is typically 2.0 to 3.5. A value within this range indicates that the patient is receiving the intended anticoagulation effect to prevent thromboembolism while maintaining a controlled risk of bleeding.

When the INR exceeds this therapeutic window, the risk of major hemorrhage escalates exponentially. An INR of 6.8 is a critically supratherapeutic value that represents a state of profound anticoagulation. At this level, the coagulation cascade is severely inhibited, and the patient is at imminent risk for life-threatening spontaneous bleeding. The provided references underscore this danger, documenting catastrophic events such as warfarin-associated intracerebral hemorrhage (ICH), which carries high mortality and disability ^[2], and spontaneous hematomas in closed compartments like the iliacus muscle or rectus sheath, which can mimic acute surgical abdomens and lead to significant blood loss and hemodynamic instability [3, 4]. These complications are a direct consequence of the excessive anticoagulant effect reflected by a dangerously elevated INR.

A systematic evaluation of each option clarifies why the INR of 6.8 demands the most immediate action:

• Option 1: PT/INR of 2.5 — This value falls squarely within the standard therapeutic range. It indicates that the warfarin dose is achieving the desired anticoagulant effect without signaling an elevated bleeding risk. No immediate intervention is required beyond routine continued monitoring ^[1].


• Option 2: PT/INR of 6.8 — This is a critical value. The risk of a major hemorrhagic event, such as an ICH or a spontaneous retroperitoneal or intramuscular hematoma, is extremely high [2, 3, 4]. This finding necessitates an immediate nursing intervention, which includes holding the warfarin dose, conducting a thorough assessment for signs of active bleeding (e.g., neurological changes, severe abdominal or flank pain, hypotension, guaiac-positive stools), and promptly notifying the healthcare provider to prepare for potential administration of vitamin K or other reversal agents.


• Option 3: Platelet count of 180,000/mm³ — This platelet count is within the normal range (150,000–400,000/mm³). While warfarin affects the coagulation cascade (secondary hemostasis), a normal platelet count indicates that primary hemostasis is intact. This value does not explain or compound the bleeding risk from an elevated INR.


• Option 4: Hemoglobin of 12.5 g/dL — This hemoglobin level is within the normal range for an adult female and low-normal for an adult male. It does not indicate active or severe anemia. While a sudden drop from a previous value would be concerning, a single stable value of 12.5 g/dL does not, in itself, require immediate intervention. The supratherapeutic INR, however, is a direct harbinger of a potential future drop in hemoglobin from acute hemorrhage ^[4].

The clinical priority is dictated by the immediate threat to the patient's physiological safety. An INR of 6.8 represents a state of severe, uncompensated coagulopathy. The pathophysiological mechanism is clear: warfarin inhibits vitamin K-dependent clotting factors (II, VII, IX, X), and a supratherapeutic INR indicates a near-complete suppression of these factors. This directly precipitates the complications described in the source material, where supratherapeutic anticoagulation was the common etiological factor in patients presenting with spontaneous ICH and rectus sheath hematoma [2, 4]. The nurse's most immediate role is to recognize this critical value, prevent further drug administration, and activate the chain of response to reverse the anticoagulation and assess for occult bleeding, thereby preventing the progression to a potentially fatal hemorrhagic event.